Toledo, Xian Wynn M.
HRN: 26-30-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/02/2024
12/08/2024
IV
215mg
Q8hours
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes